Lama Soubra

Image Description

Lama Soubra

Pharmacy Practice Department

01 300110 Ex: 2353


Lama Soubra

Head of Pharmacology and Therapeutics Department

Dr. Soubra received her Pharm.D degree from the Saint Joseph University (Beirut/Lebanon) faculty of pharmacy and her PhD in toxicology and risk assessment from ABIES Doctoral School (Paris V/ France). She has also completed a Post-PhD fellowship in cardiology at the Rafic Hariri University Hospital in Beirut.
Dr. Soubra was appointed as an assistant professor at BAU since 2009. She is currently responsible to develop and teach courses related to pharmacy practice and toxicology. She continually struggles to implement new teaching and assessment methodologies in her courses.
Dr. Soubra has more than 10 years of teaching experience. She also previously worked as a clinical research associate, a community pharmacist and a clinical pharmacist.
Dr. Soubra is an active member of many national professional committees. She received recognitions from the ACCP (2012) and from The OPL (2014) for her significant contributions to the advancement of the profession.
Dr. Soubra's research interests focus on clinical pharmacy practice, the optimization of pharmacotherapy in the institutional and ambulatory settings, and cardiovascular diseases.




Teaching Experience

1.Spring 2009- till present: full time assistant professor teaching toxicology, therapeutics and clinical pharmacy courses.
2.Course coordinator for experiential clinical courses since 2010.
3.2006- fall 2009: Part time lecturer at the Lebanese International University teaching toxicology, therapeutics and clinical pharmacokinetics courses.

Teaching Expertise:
1.Pharmacotherapy of CNS disorders, cardiovascular disorders, and gastrointestinal disorders.
2.Toxicology and Clinical toxicology.
3. Pharmacokinetics.


Research Interest and Recent publications

Research Interest:

Evidence-Based medicine and clinical practice

Clinical Toxicology

Risk Assessment

Recent Publications:

  1. "Dietary   exposure   of   children   and   teenagers   to   benzoates,   sulphites,butylhydroxyanisol            (BHA)  and  butylhydroxytoluen(BHT) in  Beirut(Lebanon)" L. Soubra, D. Sarkis, C. Hilan, Ph. Verger. Regulatory Toxicology and Pharmacology, Volume 47, Issue 1, 2007; 47(1): 68-77.
  2. "Occurrence of total aflatoxins, ochratoxin A and deoxynivalenol in foodstuffs available on the Lebanese market and their impact on dietary exposure of children and teenagers in Beirut." L. Soubra, D. Sarkis, C. Hilan, Ph. Verger. Food AdditContam Part aChem Anal Control Expo Risk Assess, 2009; 26(2):189-20.
  3. "Variables associated with stress ulcer prophylaxis misuse". I.Issa, O.Soubra, H. Nakkash and L. Soubra. Digestive diseases and sciences,2012; 57(10): 2633-41,DOI:10.1007/s10620-012-2104-9.
  4. "Drug interaction between Azithromycin and Diltiazem may cause a QTc interval prolongation: a case report" L.Soubra, A. Mroueh, S.Kabbani. International Journal of Basic and Clinical Pharmacology,2014; 3(1): 242-6. DOI:10.5455/23192003.ijbcp20140244
  5. “Spectrum and patterns of antimicrobial resistance of uropathogens isolated from a sample of hospitalized Lebanese patients with urinary tract infections”. L. Soubra, S. Kabbani, M.F. Anwar, R. Dbouk.Journal of Global Antimicrobial Resistance, 2014; 2 (2014) 173–178, DOI: 10.1016/j.jgar.2014.01.007.
  6. “Level of A1C control and its predictorsamong Lebanese type 2 diabetic patients”. H. Nuruddin, N. Nakhoul, A.Galal, L. Soubra and M. Saleh TherAdvEndocrinolMetab, 2014; 1–10, DOI: 10.1177/2042018814544890.
  7. “The Economic Impact of Patients with Heart Failure on the Lebanese Healthcare System”. S. Tatari, L. Soubra, H. Tamim, K. Akhras, S.Kabbani. Published in: European Society of Cardiology, Heart Failure Journal, 2015, DOI: 10.1002/ehf2.12038.
  8. “Heart Failure Disease Management Program and the Six Months Readmission Rate”S. Tatari, A. Mourad, N. Shasha, A. Adhami, R. Osman, A. El-Sayed,L. Soubra, H. Tamim andS. Kabbani. Accepted article for publication in: European society of cardiology, Heart Failure Journal, 2015.
  9. “Factors associated with hypertension prevalence and control among Lebanese type 2 diabetic patients”. Lama Soubra, HananNureddin, Amal Galal Omar, Mounzer Saleh. International journal of pharmacy and pharmaceutical sciences.2016; 8(10): 153-159.
  10. “Statin prescription strategies and atherogenic cholesterol goals attainment in Lebanese coronary artery disease patients”. Lama Soubra, Thourayadoumiaty, Youssef Fattouh. Int J Clin Pharm (2017) 39:919–926
  11. Heart Failure Disease Management Program and the Six Months Readmission Rate. Tatari S, Mourad AR, Shasha N, Adhami A, Osman R, Soubra L et al. JOJ Nurse Health Care. 2017; 2(1): 555579.
  12. Effect of Interprofessional Education on Role Clarification and Patient Care Planning by Health Professions Students. Soubra L, Badr S, Zahran I, AboulSeoud M. Health Professions Education (2018)
  13.  Current practices of community pharmacists in counseling patients on smoking cessation in Beirut: a questionnaire-based study. M. Issa, M. Elsolh and L. Soubra. BAU journal of health and well-being 2018:1(1):55-67


  1. Member of the national quality assurance technical committee working on the preparation, and implementation of accreditation standards for pharmacy programs at the national level since 2017.
  2. Member of the quality assurance committee working on the preparation, and implementation of accreditation standardsat the faculty level since 2012.
  3. Member of the curriculum committee responsible for developing and enhancing the undergraduate and the Pharm D programs since 2012 at the faculty of pharmacy, Beirut Arab University.
  4. Member of the Drug Committee at the National Security Fund and the Ministry of Public Health (clinical part).
  5. Member of the Continuing Education committee at the Lebanese Order of Pharmacists.
  6. Member of the clinical pharmacy committee at the Lebanese order of pharmacist responsible for developing, experiential learning program, residency curriculum at the national level and the elaboration of the national law for clinical pharmacy practice.
  7. Member of the scientific committee at the Lebanese Order of Pharmacists 2012-2016.
  8. Member of the academic board responsible for developing national competency framework for pharmacists at entry to practice.
  9. Member of the national committee at the Ministry of Education and Higher Education for setting accreditation standards for pharmacy programs since 2016.
  10. Member of the national examination committee for pharmacist at entry to practice (Colloquium) since 2007.
  11. Member of the examination committee for pharmacists at the council of public services 2010-2012.
  12. Member of the TDS (WHO food safety network) since 2006.
  13. Member of the Inter-professional education committee for medical sector, representing faculty of pharmacy and responsible to develop Interprofessional education program at Beirut Arab University since 2014.

Awards and Recognition

1. Recognized by the American College of Clinical Pharmacy (ACCP) year 2011-2012, for developing clinical pharmacy practice in Lebanon.

2. Recognized by OPL year 2014-2015 for advancing the profession through teaching and community service.